RESNA is a standards developing organization accredited by the American National Standards Institute (ANSI).
Circadian disruption is prevalent among neurodegenerative populations, to include those with Alzheimer’s, Parkinson’s, and Huntington’s disease. Poor sleep at night and sleepiness during the day has the potential to contribute to negative behavior outcomes, decreased ability to participate in meaningful activities, and increased fall risk. Exogenous drug interventions may add to an already burdensome medication regiment and may cause unwanted behavioral symptoms, such as increased aggression. Additional investigation into non-pharmacological interventions for abnormal circadian rhythms specific to this population is warranted. Assistive technology intervention options include bright light therapy, continuous positive airway pressure systems, relaxation apps, and sleep tracking apps.
Julie Faieta is a PhD student at Ohio State
Carment P. DiGiovine PhD, ATP/SMS, RET